Regulation of bone turnover by sex steroids in men

Journal of Bone and Mineral Research

Volumn 23, Issue 5, 2008, Pages 705-714

  Sanyal, Arunik ^a   Hoey, Kelley A ^a   Mödder, Ulrike I ^a   Lamsam, Jesse L ^a   McCready, Louise K ^a   Peterson, James M ^a   Achenbach, Sara J ^a   Oursler, Merry Jo ^a   Khosla, Sundeep ^a,b  

^a Mayo Clinic College of Medicine   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Bone turnover; Cytokines; Male osteoporosis; RANKL

Indexed keywords

AROMATASE INHIBITOR; BIOCHEMICAL MARKER; CARBOXY TERMINAL TELOPEPTIDE; CD3 ANTIGEN; CYTOKINE; ESTRADIOL; FOLLITROPIN; GAMMA INTERFERON; GONADORELIN AGONIST; INTERLEUKIN 1 RECEPTOR ACCESSORY PROTEIN; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PROTEIN TRACP5B; SEX HORMONE; TESTOSTERONE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BONE MARROW BIOPSY; BONE MARROW CELL; BONE TURNOVER; CELL SELECTION; FOLLITROPIN BLOOD LEVEL; FOLLITROPIN RELEASE; HORMONAL REGULATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MONOCYTE; NUCLEOTIDE SEQUENCE; OSTEOBLAST; OSTEOLYSIS; REGULATORY MECHANISM; T LYMPHOCYTE;

AGED; AGED, 80 AND OVER; BONE REMODELING; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FOLLICLE STIMULATING HORMONE; HUMANS; MALE; MIDDLE AGED; RANK LIGAND; RNA, MESSENGER;

EID: 42449123645     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.071212     Document Type: Article

References (24)

1. Khosla S, Melton LJ, Riggs BL 2002 Estrogen and the male skeleton. J Clin Endocrinol Metab 87:1443-1450.
2. Falahati-Nini A, Riggs BL, Atkinson EJ, O'Fallon WM, Eastell R, Khosla S 2000 Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest 106:1553-1560.
3. Leder BZ, LeBlanc KM, Schoenfeld DA, Eastell R, Finkelstein JS 2003 Differential effects of androgens and estrogens on bone turnover in normal men. J Clin Endocrinol Metab 88:204-210.
4. Sun L, Peng Y, Sharrow AC, Iqbal J, Zhang Z, Papachristou DJ, Zaidi S, Zhu LL, Yaroslavskiy BB, Zhou H, Zallone AZ, Sairam MR, Kumar TR, Bo W, Braun JJ, Cardoso-Landa L, Schaffler MB, Moonga BS, Blair HC, Zaidi M 2006 FSH directly regulates bone mass. Cell 125:247-260.
5. Gao J, Tiwari-Pandey R, Samadfam R, Yang Y, Miao D, Karaplis AC, Sairam MR, Goltzman D 2007 Altered ovarian function affects skeletal homeostasis independent of the action of follicle-stimulating hormone (FSH). Endocrinology 148:2613-2621.
6. Zaidi M, Sun L, Kumar TR, Sairam MR, Blair HC 2006 Both FSH and sex steroids influence bone mass (response). Cell 127:1080-1081.
7. Zaidi M 2007 Skeletal remodeling in health and disease. Nat Med 13:791-801.
8. Manolagas SC, Jilka RL 1995 Bone marrow, cytokines, and bone remodeling: Emerging insights into the pathophysiology of osteoporosis. N Engl J Med 332:305-311.
9. Eghbali-Fatourechi G, Khosla S, Sanyal A, Boyle WJ, Lacey DL, Riggs BL 2003 Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. J Clin Invest 111:1221-1230.
10. Pacifici R, Rifas L, McCracken R, Vered I, McMurtry C, Avioli LV, Peck WA 1989 Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release. Proc Natl Acad Sci USA 86:2398-2402.
11. Roggia C, Gao Y, Cenci S, Weitzmann MN, Toraldo G, Isaia G, Pacifici R 2001 Up-regulation of TNF-producing T cells in the bone marrow: A key mechanism by which estrogen deficiency induces bone loss in vivo. Proc Natl Acad Sci USA 98:13960-13965.
12. Kimble RB, Vannice JL, Bloedow DC, Thompson RC, Hopfer W, Kung VT, Brownfield C, Pacifici R 1994 Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats. J Clin Invest 93:1959-1967.
13. Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Spelsberg TC, Riggs BL 1999 Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells. Endocrinology 140:4367-4370.
14. Emery JG, McDonnell P, Burke MB, Deen KC, Lyn S, Silverman C, Dul E, Appelbaum ER, Eichman C, DiPrinzio R, Dodds RA, James IE, Rosenberg M, Lee JC, Young PR 1998 Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. J Biol Chem 273:14363-14367.
15. Gao Y, Grassi F, Ryan MR, Terauchi M, Page K, Yang X, Weitzmann MN, Pacifici R 2007 IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation. J Clin Invest 117:122-132.
16. Luster AD, Weinshank RL, Feinman R, Ravetch JV 1988 Molecular and biochemical characterization of a novel gamma-interferon-inducible protein. J Biol Chem 263:12036-12043.
17. He H, Tan CK, Downey KM, So AG 2001 A tumor necrosis factor alpha and interleukin 6-inducible protein that interacts with the small subunit of DNA polymerase delta and proliferating cell nuclear antigen. Proc Natl Acad Sci USA 98:11979-11984.
18. Sokolnicki L, Khosla S, Charkondian N 2007 Effects of testosterone and estradiol on cutaneous vasodilation during local warming in older men. Am J Physiol Endocrinol Metab 293:E1426-E1429.
19. Henriksen K, Tanko LB, Qvist P, Delmas PD, Christiansen C, Karsdal MA 2007 Assessment of osteoclast number and function: Application in the development of new and improved treatment modalities for bone diseases. Osteoporos Int 18:681-685.
20. Shevde NK, Bendixen AC, Dienger KM, Pike JW 2000 Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression. Proc Natl Acad Sci USA 97:7829-7834.
21. Srivastava S, Toraldo G, Weitzmann MN, Cenci S, Ross FP, Pacifici R 2001 Estrogen decreases osteoclast formation by down-regulating receptor activator of NF-kB ligand (RANKL)-induced JNK activation. J Biol Chem 276:8836-8840.
22. Nakamura T, Imai Y, Matsumoto T, Sato S, Takeuchi K, Igarashi K, Harada Y, Azuma Y, Krust A, Yamamoto Y, Nishina H, Takeda S, Takayanagi H, Metzger D, Kanno J, Takaoka K, Martin TJ, Chambon P, Kato S 2007 Estrogen prevents bone loss via estrogen receptor alpha and induction of fas ligand in osteoclasts. Cell 130:811-823.
23. Charatcharoenwitthaya N, Khosla S, Atkinson EJ, McCready LK, Riggs BL 2007 Effect of blockade of TNF-a and interleukin-1 action on bone resorption in early postmenopausal women. J Bone Miner Res 22:724-729.
24. Masuzawa T, Miyaura C, Onoe Y, Kusano K, Ohta H, Nozawa S, Suda T 1994 Estrogen deficiency stimulates B lymphopoiesis in mouse bone marrow. J Clin Invest 94:1090-1097.